Effect

Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, Zepbound

admin May 15, 2024 0

©felipe caparros/shutterstock.com Amgen’s novel weight loss drug candidate maridebart cafraglutide (MariTide) showed significant promise in a Phase I trial (NCT04478708),...

Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, Zepbound

Mental health apps may help those waiting for care, study finds

Prospective validation of a mobile health application for blood pressure management in patients with hypertensive disorders of pregnancy: study protocol for a randomized controlled trial | Trials

Mobile Medical Apps Market to Observe Astonishing Growth of

Evaluating Usability of and Satisfaction with mHealth app in Rural and Remote Areas -Germany GIZ Collaboration in Bosnia-Herzegovina to Optimize Type 1 Diabetes Care

Qure.ai pursuing large AI with $65M Series D funding and more briefs

Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, Zepbound

You may have missed

Mental health apps may help those waiting for care, study finds

Prospective validation of a mobile health application for blood pressure management in patients with hypertensive disorders of pregnancy: study protocol for a randomized controlled trial | Trials

Mobile Medical Apps Market to Observe Astonishing Growth of

Evaluating Usability of and Satisfaction with mHealth app in Rural and Remote Areas -Germany GIZ Collaboration in Bosnia-Herzegovina to Optimize Type 1 Diabetes Care

Qure.ai pursuing large AI with $65M Series D funding and more briefs